Acorn Genetics
Develops portable molecular testing devices, assays, and nanopore sequencing technology.
Raising now
Status unconfirmedRaising on StartEngine Primary, LLC
- Target, per the Form C
- $20,000
- Maximum, per the Form C
- $1,235,000
- Closes
- Dec 28, 2026
From the SEC Form C
- Security (as filed)
- Simple Agreement for Future Equity
- Filed
- Sep 28, 2026
- Incorporated in
- DE
- Employees
- 5
- Revenue, last fiscal year
- $0
- Net income, last fiscal year
- -$890,634
EarlySignals' view, not the portal's
Our potential score, six-dimension radar and research are for members.
Figures are the portal's own, as of the date shown. Not investment advice; EarlySignals takes no payment from issuers or portals.